Down‐regulated microRNA‐152 induces aberrant DNA methylation in hepatitis B virus–related hepatocellular carcinoma by targeting DNA methyltransferase 1

The hepatitis B virus (HBV) X protein has been implicated as a potential trigger of the epigenetic modifications of some genes during hepatocarcinogenesis, but the underlying mechanisms remain unknown. MicroRNAs (miRNAs), which are noncoding RNAs that regulate gene expression, are involved in diverse biological functions and in carcinogenesis. In this study, we investigated whether some miRNAs are aberrantly expressed and involved in the regulation of the abnormal DNA methylation status in HBV‐related hepatocellular carcinoma (HCC). Our results showed that the expression of microRNA‐152 (miR‐152) was frequently down‐regulated in HBV‐related HCC tissues in comparison with adjacent noncancerous hepatic tissues and was inversely correlated to DNA methyltransferase 1 (DNMT1) messenger RNA (mRNA) expression in HBV‐related HCCs. The forced expression of miR‐152 in liver cell lines resulted in a marked reduction of the expression of DNMT1 at both the mRNA and protein levels by directly targeting the 3′ untranslated regions of DNMT1. This in turn led to a decrease in global DNA methylation, whereas inhibition of miR‐152 caused global DNA hypermethylation and increased the methylation levels of two tumor suppressor genes, glutathione S‐transferase pi 1 (GSTP1) and E‐cadherin 1 (CDH1). Conclusion: Our findings suggest that miR‐152 is frequently down‐regulated and regulates DNMT1 in HBV‐related HCC. These findings support a tumor‐suppressive role of miR‐152 in the epigenetic aberration of HBV‐related HCC and the potential development of miRNA‐based targeted approaches for the treatment of HBV‐related HCC. HEPATOLOGY 2010

[1]  Shuhan Sun,et al.  Up‐regulated microRNA‐143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression , 2009, Hepatology.

[2]  C. Bloomfield,et al.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.

[3]  M. Torbenson,et al.  Methylation regulates hepatitis B viral protein expression. , 2009, The Journal of infectious diseases.

[4]  Ze-Guang Han,et al.  Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. , 2009, Journal of hepatology.

[5]  Yuquan Wei,et al.  Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis B virus X protein. , 2009, Journal of proteome research.

[6]  A. Valencia,et al.  The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. , 2008, Genome research.

[7]  M. Yuen,et al.  Chronic hepatitis B--new goals, new treatment. , 2008, The New England journal of medicine.

[8]  Thomas D. Schmittgen,et al.  Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. , 2008, Cancer research.

[9]  M. Torbenson,et al.  Hepatitis B viral DNA is methylated in liver tissues , 2007, Journal of viral hepatitis.

[10]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[11]  P. Arora,et al.  Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. , 2007, Cancer research.

[12]  E. Yu,et al.  Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. , 2007, Gastroenterology.

[13]  M. Esteller.  Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[14]  F. Wang,et al.  The Upregulation of Expressed Proteins in HepG2 Cells Transfected by the Recombinant Plasmid‐containing HBx Gene , 2007, Scandinavian journal of immunology.

[15]  H. Hsu,et al.  Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. , 2007, Lung cancer.

[16]  J. Byrd,et al.  Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method , 2007, Nucleic acids research.

[17]  Molly Megraw,et al.  miRGen: a database for the study of animal microRNA genomic organization and function , 2006, Nucleic Acids Res..

[18]  C. Croce,et al.  MicroRNA expression and function in cancer. , 2006, Trends in molecular medicine.

[19]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[20]  O. Kent,et al.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.

[21]  Peter A. Jones,et al.  Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.

[22]  John M Bennett,et al.  Decitabine improves patient outcomes in myelodysplastic syndromes , 2006, Cancer.

[23]  K. Livak,et al.  Real-time quantification of microRNAs by stem–loop RT–PCR , 2005, Nucleic acids research.

[24]  D. Min,et al.  Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1 , 2005, Oncogene.

[25]  S. Matsui,et al.  Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. , 2005, Cancer research.

[26]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[27]  HsinPaiLI,et al.  Epigenetic changes in virus-associated human cancers , 2005 .

[28]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[29]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[30]  G. Hu,et al.  HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice , 2004, Hepatology.

[31]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[32]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[33]  I. Bièche,et al.  Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  Huidong Shi,et al.  Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. , 2003, Cancer research.

[35]  S. Hirohashi,et al.  Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas , 2003, International journal of cancer.

[36]  D. Steinemann,et al.  Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma , 2003, Oncogene.

[37]  E. Yu,et al.  Expression of DNA methyltransferases in multistep hepatocarcinogenesis. , 2003, Human pathology.

[38]  M. Robert,et al.  DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells , 2003, Nature Genetics.

[39]  W. Yeo,et al.  Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[41]  H Ishii,et al.  Expression of mRNA for DNA methyltransferases and methyl‐CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis , 2001, Hepatology.

[42]  水野 晋一,et al.  Expression of DNA methyltransferases DNMT1,3A and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia , 2001 .

[43]  R. Singal,et al.  DNA methylation. , 1999, Blood.

[44]  G. Jay,et al.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice , 1991, Nature.

[45]  H. Hsu,et al.  Detection of hepatitis B virus DNA in hepatocellular carcinoma: methylation of integrated viral DNA. , 1988, Journal of virological methods.